Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation

John M. Ringman, Karen H. Gylys, Luis D. Medina, Michelle Fox, Vladimir Kepe, Deborah L. Flores, Liana G. Apostolova, Jorge R. Barrio, Gary Small, Daniel H. Silverman, Erin Siu, Stephen Cederbaum, Silva Hecimovic, Martina Malnar, Suma Chakraverty, Alison M. Goate, Thomas D. Bird, James B. Leverenz

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Familial Alzheimer's disease (AD) due to PSEN1 mutations provides an opportunity to examine AD biomarkers in persons in whom the diagnosis is certain. We describe a 55 year-old woman with clinically probable AD and a novel PSEN1 mutation who underwent genetic, clinical, biochemical and magnetic resonance and nuclear imaging assessments. We also describe neuropathological findings in her similarly affected brother. Neuropsychological testing confirmed deficits in memory, visuospatial and language function. CSF t-tau and p-tau181 were markedly elevated and Aβ42 levels reduced. FDG-PET revealed hypometabolism in the left parietotemporal cortex. FDDNP-PET showed increased binding of tracer in medial temporal and parietal lobes and in the head of the caudate and anterior putamen bilaterally. Neuropathological examination of her brother showed the typical findings of AD and the striatum demonstrated amyloid pathology and marked neurofibrillary pathology beyond that typically seen in late-onset AD. A novel S212Y substitution in PSEN1 was present in the index patient and her affected brother but not in an older unaffected sister. An in vitro assay in which the S212Y mutation was introduced in cell culture confirmed that it was associated with increased production of Aβ42. We describe biochemical, imaging, and neuropathological changes in a pedigree with a novel PSEN1 mutation. This allows us to validate the pathogenicity of this mutation and the indices used to assess AD.

Original languageEnglish (US)
Pages (from-to)287-292
Number of pages6
JournalNeuroscience Letters
Volume487
Issue number3
DOIs
StatePublished - Jan 10 2011
Externally publishedYes

Keywords

  • Alzheimer's disease
  • Amyloid imaging
  • Beta-amyloid
  • Cerebrospinal fluid
  • FDDNP
  • FDG
  • PSEN1
  • Positron emission tomography
  • S212Y
  • Striatum
  • Tau

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation'. Together they form a unique fingerprint.

  • Cite this

    Ringman, J. M., Gylys, K. H., Medina, L. D., Fox, M., Kepe, V., Flores, D. L., Apostolova, L. G., Barrio, J. R., Small, G., Silverman, D. H., Siu, E., Cederbaum, S., Hecimovic, S., Malnar, M., Chakraverty, S., Goate, A. M., Bird, T. D., & Leverenz, J. B. (2011). Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation. Neuroscience Letters, 487(3), 287-292. https://doi.org/10.1016/j.neulet.2010.10.039